Teresa K. Woodruff | |
---|---|
Interim President of Michigan State University | |
In office November 4, 2022 – March 4, 2024 | |
Preceded by | Samuel L. Stanley Jr. |
Succeeded by | Kevin Guskiewicz |
Provost of Michigan State University | |
In office August 1, 2020 – November 4, 2022 | |
Preceded by | June Youatt |
Succeeded by | Thomas D. Jeitschko (interim) |
Personal details | |
Spouse | Thomas O'Halloran |
Education | Olivet Nazarene University (BS) Northwestern University (PhD) |
Scientific career | |
Fields | Reproductive Biology, Obstetrics, Gynecology, Biomedical Engineering |
Institutions | |
Teresa Kaye Woodruff is an American medical researcher in human reproduction and oncology, with a focus on ovarian biology, endocrinology, and women's health. She joined Michigan State University as the Provost and Executive Vice President for Academic Affairs in August 2020.[1] Woodruff served as the interim President of Michigan State University from November 4, 2022 to March 4, 2024, following the resignation of Samuel L. Stanley.[2] She was previously the Thomas J. Watkins Memorial Professor and Vice Chair for Research and Chief of the Division of Reproductive Science in Medicine in the Department of Obstetrics and Gynecology at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois.
Woodruff was previously Dean of the Graduate School and Professor in the McCormick School of Engineering at Northwestern University.[3] She is credited with coining the term oncofertility and founded the Oncofertility Consortium at Northwestern Memorial Hospital. She is also founder and chief of the Division of Fertility Preservation and founder and director of the Women's Health Research Institute at Northwestern University.